159 related articles for article (PubMed ID: 16118330)
1. Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid).
Clement B; Mau S; Deters S; Havemeyer A
Drug Metab Dispos; 2005 Nov; 33(11):1740-7. PubMed ID: 16118330
[TBL] [Abstract][Full Text] [Related]
2. Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2.
Clement B; Demesmaeker M
Drug Metab Dispos; 1997 Nov; 25(11):1266-71. PubMed ID: 9351903
[TBL] [Abstract][Full Text] [Related]
3. Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: characterization of the two reactions and genotoxic potential of guanoxabenz.
Clement B; Demesmaeker M; Linne S
Chem Res Toxicol; 1996 Jun; 9(4):682-8. PubMed ID: 8831810
[TBL] [Abstract][Full Text] [Related]
4. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
[TBL] [Abstract][Full Text] [Related]
5. NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans.
Kurian JR; Bajad SU; Miller JL; Chin NA; Trepanier LA
J Pharmacol Exp Ther; 2004 Dec; 311(3):1171-8. PubMed ID: 15302896
[TBL] [Abstract][Full Text] [Related]
6. Characterization and partial purification of the rat and human enzyme systems active in the reduction of N-hydroxymelagatran and benzamidoxime.
Andersson S; Hofmann Y; Nordling A; Li XQ; Nivelius S; Andersson TB; Ingelman-Sundberg M; Johansson I
Drug Metab Dispos; 2005 Apr; 33(4):570-8. PubMed ID: 15640373
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of the protein components of the liver microsomal O2-insensitive NADH-benzamidoxime reductase.
Clement B; Lomb R; Möller W
J Biol Chem; 1997 Aug; 272(31):19615-20. PubMed ID: 9235969
[TBL] [Abstract][Full Text] [Related]
8. Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase.
Saulter JY; Kurian JR; Trepanier LA; Tidwell RR; Bridges AS; Boykin DW; Stephens CE; Anbazhagan M; Hall JE
Drug Metab Dispos; 2005 Dec; 33(12):1886-93. PubMed ID: 16131524
[TBL] [Abstract][Full Text] [Related]
9. Reduction of N-hydroxy-sulfonamides, including N-hydroxy-valdecoxib, by the molybdenum-containing enzyme mARC.
Havemeyer A; Grünewald S; Wahl B; Bittner F; Mendel R; Erdélyi P; Fischer J; Clement B
Drug Metab Dispos; 2010 Nov; 38(11):1917-21. PubMed ID: 20699408
[TBL] [Abstract][Full Text] [Related]
10. The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs.
Gruenewald S; Wahl B; Bittner F; Hungeling H; Kanzow S; Kotthaus J; Schwering U; Mendel RR; Clement B
J Med Chem; 2008 Dec; 51(24):8173-7. PubMed ID: 19053771
[TBL] [Abstract][Full Text] [Related]
11. Reduction of N-hydroxylated compounds: amidoximes (N-hydroxyamidines) as pro-drugs of amidines.
Clement B
Drug Metab Rev; 2002 Aug; 34(3):565-79. PubMed ID: 12214667
[TBL] [Abstract][Full Text] [Related]
12. Reduction of Nomega-hydroxy-L-arginine to L-arginine by pig liver microsomes, mitochondria, and human liver microsomes.
Clement B; Kunze T; Heberling S
Biochem Biophys Res Commun; 2006 Oct; 349(2):869-73. PubMed ID: 16959215
[TBL] [Abstract][Full Text] [Related]
13. Oxygen-insensitive enzymatic reduction of oximes to imines.
Heberling S; Girreser U; Wolf S; Clement B
Biochem Pharmacol; 2006 Jan; 71(3):354-65. PubMed ID: 16324684
[TBL] [Abstract][Full Text] [Related]
14. Involvement of stearoyl-CoA desaturase in the reduction of amidoxime prodrugs.
Reh R; Ozols J; Clement B
Xenobiotica; 2008 Sep; 38(9):1177-90. PubMed ID: 18609446
[TBL] [Abstract][Full Text] [Related]
15. N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Possible relationship to the biological oxidation of arginine to NG-hydroxyarginine, citrulline, and nitric oxide.
Clement B; Jung F
Drug Metab Dispos; 1994; 22(3):486-97. PubMed ID: 8070328
[TBL] [Abstract][Full Text] [Related]
16. Reduction of amphetamine hydroxylamine and other aliphatic hydroxylamines by benzamidoxime reductase and human liver microsomes.
Clement B; Behrens D; Möller W; Cashman JR
Chem Res Toxicol; 2000 Oct; 13(10):1037-45. PubMed ID: 11080052
[TBL] [Abstract][Full Text] [Related]
17. Defining the Role of the NADH-Cytochrome-b5 Reductase 3 in the Mitochondrial Amidoxime Reducing Component Enzyme System.
Plitzko B; Havemeyer A; Bork B; Bittner F; Mendel R; Clement B
Drug Metab Dispos; 2016 Oct; 44(10):1617-21. PubMed ID: 27469001
[TBL] [Abstract][Full Text] [Related]
18. Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme.
Havemeyer A; Bittner F; Wollers S; Mendel R; Kunze T; Clement B
J Biol Chem; 2006 Nov; 281(46):34796-802. PubMed ID: 16973608
[TBL] [Abstract][Full Text] [Related]
19. [Transport of electrons from mitochondria to microsomes in the reconstituted system of cell organelles].
Chistiakov VV; Pospelova LN
Biokhimiia; 1982 Jan; 47(1):55-61. PubMed ID: 6802189
[TBL] [Abstract][Full Text] [Related]
20. N,N'-dihydroxyamidines: a new prodrug principle to improve the oral bioavailability of amidines.
Reeh C; Wundt J; Clement B
J Med Chem; 2007 Dec; 50(26):6730-4. PubMed ID: 18052320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
